Hallux Rigidus: Update on Conservative Management.
Conservative
Hallux rigidus
Injection
Nonoperative
Orthotics
Therapy
Journal
Foot and ankle clinics
ISSN: 1558-1934
Titre abrégé: Foot Ankle Clin
Pays: United States
ID NLM: 9615073
Informations de publication
Date de publication:
Sep 2024
Sep 2024
Historique:
medline:
28
7
2024
pubmed:
28
7
2024
entrez:
27
7
2024
Statut:
ppublish
Résumé
Hallux rigidus is a degenerative arthritic condition affecting the first metatarsophalangeal joint. Prevalence in patients aged 50 years and above is estimated at 20% to 30%, with a portion being symptomatic. Conservative treatment's efficacy is linked to initial pain levels; though shoe modifications and insoles are commonly recommended, their true effectiveness lacks strong evidence. Injection therapy, including corticosteroids and hyaluronic acid, demonstrates varied outcomes, with about 50% of patients undergoing surgery within 1 to 2 years. The condition's etiology remains elusive, but recent biomechanical hypotheses hold promise.
Identifiants
pubmed: 39068017
pii: S1083-7515(23)00169-9
doi: 10.1016/j.fcl.2023.09.010
pii:
doi:
Substances chimiques
Hyaluronic Acid
9004-61-9
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
405-415Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have no commercial or financial conflicts of interest related to this work. All pictures and x-rays are from Dr Hanselman’s records.